Australian Patent Granted to NurExone Covering Stem Cell-Derived Exosome Production Life Science Investing
AbbVie Submits Regulatory Application to FDA for SKYRIZI® Subcutaneous Induction for Adults with Moderately to Severely Active Crohn's Disease Pharmaceutical Investing
Eton Pharmaceuticals Announces Initiation of Clinical Study for Product Candidate ET-700 Life Science Investing
Bristol Myers Squibb and Pfizer to Make Eliquis® Available via Mark Cuban Cost Plus Drug Company Life Science Investing
Nektar Therapeutics Announces Closing of $373.8 Million Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares Life Science Investing
AbbVie Provides Update on TrenibotulinumtoxinE Biologics License Application in the U.S. Pharmaceutical Investing
Cumberland Pharmaceuticals Announces Strategic Transaction to Integrate Commercial Business with Apotex Life Science Investing
Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration Life Science Investing
Corvus Pharmaceuticals Appoints Andrew C. Chan, M.D., Ph.D., to Board of Directors Life Science Investing
